Discussing complementary therapies in an oncology setting.

Area of Science:

• Integrative Oncology
• Pharmacology
• Patient Safety

Background:

• Many cancer patients use herbal or biologic therapies alongside conventional treatments.
• Concurrent use of complementary medicines can lead to adverse drug-herb interactions or beneficial effects.
• A significant gap exists in patient disclosure of complementary medicine use to healthcare teams.

Purpose of the Study:

• To explore barriers to open communication regarding complementary therapies in cancer care.
• To emphasize the healthcare professional's responsibility in initiating discussions about complementary treatments.
• To provide strategies and resources for informed dialogue on complementary medicine use.

Main Methods:

• Literature review on drug-herb interactions and communication in oncology.
• Analysis of barriers to patient-provider communication about complementary medicine.
• Development of strategies for initiating and guiding patient-provider dialogues.

Main Results:

• Adverse drug-herb interactions are a significant risk when complementary therapies are used with conventional cancer treatments.
• Benefits, such as reduced side effects and improved well-being, can also occur.
• Lack of open communication poses medical and legal risks, highlighting the need for proactive provider engagement.

Conclusions:

• Healthcare professionals must initiate conversations about complementary medicine use due to potential risks and benefits.
• Addressing communication barriers is essential for ensuring patient safety and optimizing integrative cancer care.
• Providing resources and strategies can facilitate informed decision-making for patients using complementary therapies.